Printed from Voxsanity (voxsanity.com.au) — NCT05759572 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Breast Cancer
Phase 2 Breast Cancer Trial, Recruiting
NCT05759572
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman aged 18 to 75 years old
- You have been diagnosed with invasive breast cancer that has been confirmed by a tissue biopsy, and your cancer is hormone receptor-positive (ER and/or PR positive) and HER2-negative (based on specific lab test results)
- Your breast cancer has been identified as a specific subtype called "SNF-4," confirmed by testing at Fudan University Affiliated Cancer Hospital's breast cancer laboratory (confirm with trial site)
- Your cancer is either locally advanced and cannot be fully removed or treated locally, or it has spread to other parts of your body (metastatic)
- Your cancer can be measured on scans, or you have bone lesions of a specific type even if nothing else is measurable
- Your blood counts are at healthy enough levels — including white blood cells, platelets, and hemoglobin
- You have not previously received chemotherapy or targeted therapy for your metastatic (spread) cancer
- Your liver and kidney function levels are adequate (confirm with trial site for specific values)
- You are well enough to carry out basic daily activities (rated 0–2 on a standard health scale) and your life expectancy is at least 3 months
- You are willing to participate, have signed a consent form, and agree to attend follow-up appointments
Who may not be able to join:
- You have already received chemotherapy, radiotherapy, immunotherapy, or major surgery to treat your metastatic cancer
- You have brain metastases (cancer that has spread to the brain) that are causing symptoms, have not been treated, or are getting worse, especially if you need steroids or other medications to manage symptoms
- You have had a serious heart condition in the last 6 months, such as heart failure, angina, a heart attack, or irregular heart rhythms
- You are currently pregnant or breastfeeding
- You have had another type of cancer in the past 5 years (except for certain fully cured skin cancers or a specific type of non-invasive cervical condition)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Phase 2
Sponsor
Registry
ClinicalTrials.gov
Start date
1 February 2023
Est. completion
1 November 2025
Where this trial is recruiting
🇨🇳 China
Primary endpoints
PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.